| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |